-
Aurora Cannabis Analyst Welcomes Restructuring, But Sales Trends Are 'Disappointing'
Friday, February 7, 2020 - 1:50pm | 353A slew of material announcements led to a trading halt on Aurora Cannabis Inc (NYSE: ACB) Thursday afternoon. Management announced 500 layoffs, the departure of CEO Terry Booth, expectations of asset impairment charges, and amendments to its secured credit facilities. Shares plunged during the day...
-
Analyst Dives Into Cannabis 2.0, Says There Are Fewer Suppliers And A More Concentrated Market
Wednesday, January 22, 2020 - 8:59am | 334A survey of the provincial board’s online stores presented a more concentrated market for cannabis 2.0 products than for dried flower, Cantor Fitzgerald analyst Pablo Zuanic said in a Tuesday report. The 2.0 market is also characterized by fewer suppliers and fewer SKUs, although often out of...
-
Analyst: Cannabis Companies Cautious About The First Half Of 2020
Tuesday, January 21, 2020 - 3:21pm | 510BofA Global Research last week published an analysis forecasting its view of the possible future for Canadian-based cannabis companies in the first half of 2020. The firm met with representatives of Canada’s most valuable cannabis companies, including Aphria (NYSE: APHA), Aurora Cannabis (...
-
Aurora Cannabis Trades Down After CCO Cam Battley's Resignation
Monday, December 23, 2019 - 10:07am | 442Aurora Cannabis Inc. (NYSE: ACB), announced Saturday that Chief Corporate Officer Cam Battley has resigned effective Dec. 20. Battley joined Aurora’s team in 2016 and was promoted to CCO in 2018. In November, he was hired by MedReleaf Australia’s board, and the...
-
Analyst Says British Columbia Is Out Front In Canadian Cannabis 2.0 Rollout
Friday, December 20, 2019 - 1:42pm | 556While some cannabis companies are in no hurry to transport their 2.0 products, others are aiming for a first-mover advantage, Cantor Fitzgerald’s Pablo Zuanic said in a Thursday note, adding that “it is not all up to them.” “The timing of 2.0 availability will depend on each...
-
Tilray Launches Canadian Cannabis 2.0 Products, Completes First Export Of Medical Cannabis Extract To Switzerland
Tuesday, December 17, 2019 - 1:31pm | 607Tilray, Inc. (NASDAQ: TLRY) subsidiary High Park Holdings Ltd. announced its line of Cannabis 2.0 products Tuesday. The company’s new products include the confectionery brand Chowie Wowie, wellness brand Rmdy and the beverage brand Everie, which was developed by...
-
Analyst On Hexo Earnings: 'We Had Expected Worse'
Tuesday, December 17, 2019 - 10:25am | 398Hexo Corp (NYSE: HEXO) shares traded lower by 2.9% on Monday after the company’s fiscal first-quarter earnings came up short of market expectations. However, one analyst said Monday he “expected worse.” The Analyst Cantor Fitzgerald analyst Pablo Zuanic reiterated his Underperform...
-
The SAFE Act Could Be 2020's Biggest Cannabis Catalyst
Monday, December 16, 2019 - 12:32pm | 528Cannabis investors are hoping Canada’s Cannabis 2.0 will help improve sales growth and profitability in 2020 after a disappointing 2019. Yet the U.S. SAFE Act may be the single biggest catalyst for cannabis stocks in the coming year, Cantor Fitzgerald analyst Pablo Zuanic said in a...
-
Hexo's Q1 Report Could Be Ugly, Says Cantor Fitzgerald
Friday, December 13, 2019 - 2:02pm | 497It’s been a brutal year for cannabis stocks, and Hexo Corp (NYSE: HEXO) is no exception. With Hexo set to report first-quarter earningsMonday, one Wall Street analyst said investors should brace for more bad news. The Analyst Cantor Fitzgerald analyst Pablo Zuanic reiterated an Underperform...
-
Organigram Receives Health Canada Licenses For Chocolate Production
Friday, December 13, 2019 - 12:33pm | 334Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) said Friday that it has obtained Health Canada approval for 16 additional cultivation rooms. With the newly licensed cultivation rooms, Organiram’s Moncton campus will reach 89,000 kg of licensed capacity in year one and the...
-
Canopy Growth's Cannabis 2.0 Products Will Hit Shelves In Canada Next Month
Friday, December 6, 2019 - 12:28pm | 301Last week, Canopy Growth Corporation (TSX:WEED)(NYSE: CGC) formally unveiled its line of products set for "cannabis 2.0." The company projects that in the majority of Canadian markets, new products will hit the shelves at the beginning of January. Canopy Growth announced Friday the first...
-
Canopy Growth Is Prepared For 'Cannabis 2.0' In Canada, Analysts Say
Thursday, December 5, 2019 - 1:10pm | 456Canopy Growth Inc. (NYSE: CGC) (TSE:WEED) recently announced its new product line amid Canada's "cannabis 2.0" launch this month. Here's what the sell-side thinks. The Analysts Bank of America Merrill Lynch's Christopher Carey reiterated a Buy rating on Canopy Growth and...
-
True Leaf Secures 3 Health Canada Licenses To Cultivate, Process, Sell Medical Marijuana
Monday, November 25, 2019 - 12:28pm | 303True Leaf Brands Inc (CSE:MJ) (OTC: TRLFF) subsidiary True Leaf Cannabis Inc. said Monday it has secured Health Canada’s licenses for cultivation, processing and selling cannabis for medical purposes for its True Leaf Campus facility. The license enables True Leaf to commence with the...
-
Canopy Growth Obtains Health Canada License For Beverage Facility, Now Has All 'Cannabis 2.0' Licenses
Monday, November 25, 2019 - 10:38am | 309Canopy Growth Corporation (TSX: WEED)(NYSE: CGC) said Monday it has obtained Health Canada’s operating and secure storage license for its 150,000 square foot beverage facility. With the addition of this license, the company now has all “cannabis 2.0” connected licenses,...
-
Exclusive: Canopy Growth's CEO On The Cannabis Company's Stock Price, Growth Potential, Global Footprint
Wednesday, November 20, 2019 - 2:31pm | 892By Javier Hasse and Natan Ponieman. Canopy Growth Corp (NYSE: CGC) released second-quarter financial results that sent the stock trading lower last week. To better understand what’s going on, Benzinga reached out to CEO Mark Zekulin, who became the company’s public face after...